The role of levosimendan in phosphine-induced cardiotoxicity: evaluation of electrocardiographic, echocardiographic, and biochemical parameters-Reference-Cited by-同舟云学术

The role of levosimendan in phosphine-induced cardiotoxicity: evaluation of electrocardiographic, echocardiographic, and biochemical parameters

Published:2021-08-01 Issue:9 Volume:31 Page:631-643
ISSN:1537-6516
Container-title:Toxicology Mechanisms and Methods
language:en
Short-container-title:Toxicology Mechanisms and Methods

Author:

Armandeh Maryam¹²,Bameri Behnaz¹²,Baeeri Maryam¹²,Haghi-Aminjan Hamed³,Rahimifard Mahban¹²,Hassani Shokoufeh¹²,Hooshangi Shayesteh Mohammad Reza¹²,Khalid Madiha¹²^ORCID,Samadi Mahedeh⁴,Hosseini Rohollah¹,Masoudi Fard Majid⁵,Abdollahi Mohammad¹²^ORCID

Affiliation:

1. Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

2. Toxicology and Diseases Group, Pharmaceutical Sciences Research Center (P SRC), The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran

3. Pharmaceutical Sciences Research Center, Ardabil University of Medical Sciences, Ardabil, Iran

4. Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran

5. Department of Surgery & Radiology, Faculty of Veterinary Medicine, Tehran University, Tehran, Iran

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Toxicology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15376516.2021.1950248

Reference70 articles.

1. Molecular and biochemical evidences on the protective effects of triiodothyronine against phosphine-induced cardiac and mitochondrial toxicity

2. Levosimendan reduces myocardial damage and improves cardiodynamics in streptozotocin induced diabetic cardiomyopathy via SERCA2a/NCX1 pathway